Invention Grant
- Patent Title: Poly-ADP ribose polymerase (PARP) inhibitors
-
Application No.: US17342873Application Date: 2021-06-09
-
Publication No.: US11993585B2Publication Date: 2024-05-28
- Inventor: Taisuke Takahashi , Arthur Kluge , Bharat Lagu , Nan Ji
- Applicant: Mitobridge, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Mitobridge, Inc.
- Current Assignee: Mitobridge, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Wei Song; James M. Alburger
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61P13/12 ; C07D401/06 ; C07D403/06 ; C07D403/14 ; C07D405/14 ; C07D417/14 ; C07D471/04 ; C07D487/04 ; C07D495/04
Abstract:
The present invention is related to a pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and a compound represented by the following structural formula:
The present invention is also related a method of treating a subject with a disease which can be ameliorated by inhibition of poly(ADP-ribose)polymerase (PARP). The definitions of the variables are provided herein.
The present invention is also related a method of treating a subject with a disease which can be ameliorated by inhibition of poly(ADP-ribose)polymerase (PARP). The definitions of the variables are provided herein.
Public/Granted literature
- US20220033380A1 POLY-ADP RIBOSE POLYMERASE (PARP) INHIBITORS Public/Granted day:2022-02-03
Information query
